| Literature DB >> 35745527 |
Jia Chen1, Fei Ran1, Jinqiao Shi1, Tingting Chen1, Zhibo Zhao1, Zhuzhu Zhang1, Linan He1, Wenzhi Li1, Bingce Wang1, Xuetang Chen1, Weizhen Wang1, Youhua Long1,2.
Abstract
Kiwifruit (Actinidia chinensis) is an important commercial crop in China, and the occurrence of diseases may cause significant economic loss in its production. In the present study, a new pathogen that causes brown leaf spot disease on kiwifruit was reported. The fungus was isolated from an infected sample and identified as Fusarium graminearum based on morphological and molecular evaluation. Koch's postulates were confirmed when the pathogen was re-isolated from plants with artificially induced symptoms and identified as F. graminearum. Based on the biological characteristics of the pathogen, it was determined that: its optimal growth temperature was 25 °C; optimal pH was 7; most suitable carbon source was soluble starch; most suitable nitrogen source was yeast powder; and best photoperiod was 12 h light/12 h dark. Further investigations were conducted by determining 50% effective concentrations (EC50) of several active ingredients of biological fungicides against F. graminearum. The results showed that among the studied fungicides, tetramycin and honokiol had the highest antifungal activity against this pathogen. Our findings provide a scientific basis for the prevention and treatment of brown leaf spot disease on kiwifruit.Entities:
Keywords: Fusarium graminearum; active ingredients of biological fungicides; biological characteristics; brown leaf spot disease; kiwifruit
Year: 2022 PMID: 35745527 PMCID: PMC9229313 DOI: 10.3390/pathogens11060673
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1(A,B) Natural field symptoms of brown leaf spot on kiwifruit. (C) In the wounded inoculation method, six days after inoculation with isolate CY2 spore suspension, the artificially inoculated leaves showed brown spots similar to those observed in the orchard, while the control inoculation did not show brown spots (white and red arrows indicate the sites of inoculation). The experiment was repeated three times with similar results. (D) On the ninth day after inoculation with isolate CY2 spore suspension, the artificially inoculated leaves showed brown spots, while no symptoms were observed on the control inoculation (the dashed line indicates the major vein, white and red arrows indicate different inoculation treatments). The experiment was repeated three times with similar results.
Figure 2(A,B) Colony morphology of isolate CY2 on potato dextrose agar (PDA) after six days of cultivation. (C) Mycelia of isolate CY2 on PDA, with branches and septa. (D) Macroconidia produced on CLA with 5–6 septa. (E) The evolutionary history of the investigated Fusarium graminearum isolate CY2 (indicated by bold letters) inferred by the neighbor-joining method (1000 bootstraps for confidence level) based on the combined ITS, TEF-1α, and RPB2 genes.
Reference isolates used in the present study and their GenBank accession numbers.
| Species | Culture Accession | GenBank Accession | ||
|---|---|---|---|---|
| ITS |
|
| ||
|
| NRRL 31084 | - | MW233103 | MW233447 |
|
| LC 13775 | - | MW620072 | MW474597 |
|
| NRRL 13818 | - | MW233069 | MW233412 |
|
| NRRL 54218 | HM068326 | HM068316 | HM068336 |
|
| NRRL 26419 | GQ505688 | GQ505599 | GQ505777 |
|
| NRRL 43636 | GQ505752 | GQ505663 | GQ505841 |
|
| NRRL 54940 | - | MW233138 | MW233482 |
|
| CBS 36236 | - | MW233114 | MW233458 |
|
| NRRL 36401 | - | GQ505651 | GQ505829 |
|
| NRRL 36448 | GQ505741 | GQ505652 | GQ505830 |
|
| NRRL 3509 | NR152943 | MW233056 | MW233399 |
|
| NRRL 6491 | - | MW233057 | MW233400 |
|
| NRRL 43639 | GQ505755 | GQ505666 | GQ505844 |
|
| NRRL 43635 | GQ505751 | GQ505662 | GQ505840 |
Figure 3Mycelial diameters under different (A) temperatures, (B) pH, (C) carbon sources, (D) nitrogen sources, and (E) light time conditions. The diameters were determined after four days of cultivation of F. graminearum isolate CY2. The error bar indicates standard deviations (SD), each value is the mean ± SD of three replicates, and different lower-case letters represent significant differences at the 5% level (p < 0.05).
Figure 4(A) Mycelial growth inhibition of Fusarium graminearum isolate CY2 after the application of different active ingredients of biological fungicides under a series of concentrations, with fungicide free plates (CK) as the control. (B) EC50 value of different fungicides applied to isolate CY2. The error bar indicates standard deviations (SD), each value is the mean ± SD of three replicates, and different lower-case letters represent significant differences at the 5% level (p < 0.05).
Toxicities of different active ingredients of biological fungicides against Fusarium graminearum CY2.
| Active Ingredients of Biological Fungicides | Regression Equation | Determination | EC50 (μg mL−1) | 95% Confidence Interval |
|---|---|---|---|---|
| 98% Honokiol DP | Y = 3.4834 + 1.5742x | 0.9876 | 9.26 ± 0.11 | 7.97–10.60 |
| 98% Matrine DP | Y = 3.1989 + 1.5251x | 0.9831 | 15.2 ± 0.31 | 13.11–17.54 |
| 1.5% Tetramycin AS | Y = 4.3763 + 1.0306x | 0.9817 | 4.02 ± 0.05 | 3.10–5.23 |
| 97% Citral AS | Y = 2.1413 + 1.974x | 0.9825 | 28.6 ± 0.99 | 23.99–32.84 |
| 98% Baicalein DP | Y = 2.457 + 1.5172x | 0.9730 | 47.3 ± 0.12 | 39.31–57.23 |
Each value indicates the mean ± SD of three replicates; X and Y represent active ingredients of biological fungicides concentration and growth inhibition rate, respectively.
Primers used in the present study.
| Target | Description | Primer | Sequence 5′ → 3′ | Reference |
|---|---|---|---|---|
| ITS | Region with ribosomal RNA genes and two internal transcribed spacers | ITS1 | TCCGTAGGTGAACCTGCGG | [ |
| ITS4 | TCCTCCGCTTATTGATATGC | |||
|
| Translation elongation factor 1-α gene | EF1-728F | CATCGAGAAGTTCGAGAAGG | [ |
| EF1-986R | TACTTGAAGGAACCCTTACC | |||
|
| Second largest subunit of RNA polymerase II | fRPB2-7cR | CCCATRGCTTGTYYRCCCAT | [ |
| RPB2-5F2 | GGGGWGAYCAGAAGAAGGC | [ |
Concentration gradient of different active ingredients of biological fungicides used for treating isolate CY2.
| Active Ingredients of Biological Fungicides | Manufacturer | Concentration Gradient (μg mL−1) | ||||
|---|---|---|---|---|---|---|
| T1 | T2 | T3 | T4 | T5 | ||
| 98% Honokiol DP | Shanghai Macklin Biochemical Co., Ltd., Shanghai, China | 4 | 8 | 16 | 32 | 64 |
| 98% Matrine DP | Aladdin Industrial Corporation, Shanghai, China | 4 | 8 | 16 | 32 | 64 |
| 1.5% Tetramycin AS | Liaoning Wkioc Bioengineering Co., Ltd., Shenyang, China | 4 | 8 | 16 | 32 | 64 |
| 97% Citral AS | Aladdin Industrial Corporation, Shanghai, China | 5 | 10 | 20 | 40 | 80 |
| 98% Baicalein DP | Shanghai Macklin Biochemical Co., Ltd., Shanghai, China | 10 | 20 | 40 | 80 | 160 |
DP, dust powder; AS, aqueous solution.